{"ok":true,"trend":{"id":902046,"platform":"news","region":"global","key":"aaopt 2026: glp-1ras and ocular health","title":"AAOpt 2026: GLP-1RAs and ocular health","url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5CZFJaVnZWcDBVY0FGNlFwNFJINnJtdHhOLWRDbC1jMjBZODRoeXNoNVFWU0pLdUp1U1YxbUNJWEdSeE1LQlJJSXVLRTRhRDh5NlAwWWk3QndCcS14R1hVM2tFMjNBS2ZITkZlVWhSbHhKZzczeFBMZ1ROcUZtZw?oc=5","first_seen":"2026-10-03T20:43:24.701426Z","last_seen":"2026-10-04T02:13:37.359773Z","last_rank":27,"peak_rank":11,"last_volume":null,"peak_volume":0,"seen_count":5,"score":0.955625,"category_hint":"health","section":"health","category":"health","summary":"The American Academy of Optometry's 2026 meeting is spotlighting the ocular effects of GLP-1 receptor agonists, the class of drugs that includes semaglutide and tirzepatide. Clinicians are discussing how these widely used diabetes and weight-loss medications may affect the eye, from reported changes in diabetic retinopathy to dry-eye symptoms, and what optometrists should monitor in patients taking them.","why":"Millions of patients now take GLP-1 drugs, so eye-care specialists are urgently weighing emerging evidence about their effects on vision and retinal health.","tone":"neutral","entities":["American Academy of Optometry","GLP-1 receptor agonists","semaglutide","tirzepatide"],"summarized_at":"2026-10-04T02:45:08.740780Z","meta":{"via":"scan","lang":"en","term":"health","source":"Optometry Times","published":"Sat, 03 Oct 2026 18:28:18 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"AAOpt 2026 puts GLP-1 drugs and eye health in focus","section_name":"Health","category_name":"Health","timeline":[{"captured_at":"2026-10-03T20:43:24.701426Z","rank":11,"volume":null},{"captured_at":"2026-10-03T22:06:18.511492Z","rank":13,"volume":null},{"captured_at":"2026-10-03T23:28:36.331662Z","rank":20,"volume":null},{"captured_at":"2026-10-04T00:50:56.194047Z","rank":27,"volume":null},{"captured_at":"2026-10-04T02:13:37.359773Z","rank":27,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5CZFJaVnZWcDBVY0FGNlFwNFJINnJtdHhOLWRDbC1jMjBZODRoeXNoNVFWU0pLdUp1U1YxbUNJWEdSeE1LQlJJSXVLRTRhRDh5NlAwWWk3QndCcS14R1hVM2tFMjNBS2ZITkZlVWhSbHhKZzczeFBMZ1ROcUZtZw?oc=5","author":"Optometry Times","title":"AAOpt 2026: GLP-1RAs and ocular health","snippet":null,"posted_at":"2026-10-03T18:28:18Z","likes":null}],"elsewhere":[],"window":"7d"}}